Understanding why placebos can have therapeutic benefit

Regular readers will be familiar with the fact that new drugs for prostate cancer are often tested against a “placebo.” They may also have heard the term “the placebo effect,” which generally implies that some interventions with no known (or theoretically possible) therapeutic benefit can be demonstrated to have a very real therapeutic effect. … READ MORE …

FDA updates risks of adverse effects from treatment with finasteride

The U.S. Food & Drug Adminstration (FDA), yesterday, issued a statement about modifications to the labeling (the product prescribing information) for the two branded formulations of finasteride: Propecia® (finasteride 1 mg) and Proscar® (finasteride 5 mg). These modifications to the product labeling may be relevant to some men with or at risk for prostate cancer. … READ MORE …

Sexual orientation and impact of androgen deprivation therapy

An article by a group of Romanian researchers published in October this year may have some controversial implications — so we want to be very clear that we don’t think too much should be read into it unless their data can be replicated by others. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,133 other followers